Literature DB >> 15168027

[Pre-auricular tumors in an infant. Differential diagnosis of neuroectodermal syndromes].

W-H Boehncke1, J Schultz, R Kaufmann, F R Ochsendorf.   

Abstract

BACKGROUND: Neuroectodermal syndromes are complex because of their rarity and overlapping clinical manifestations making differential diagnosis problematic. CASE REPORT: A 2-year old girl presented with a phenotype characterized by bilateral pre-auricular tags, a fistula of the right cheek, hemifacial microsomia, and a limbus dermoid on the right eye. This constellation is characteristic for the Goldenhar syndrome. Following excision of the tags and fistula along with a keratoplasty, the child developed normally.
CONCLUSION: The exact diagnosis of a neuroectodermal syndrome facilitates identification of associated symptoms. Early surgical therapy may prevent the development of functional deficits.

Entities:  

Mesh:

Year:  2004        PMID: 15168027     DOI: 10.1007/s00105-004-0748-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

1.  Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral cutaneous and visceral involvement.

Authors:  P Rubegni; M Risulo; P Sbano; G Buonocore; S Perrone; M Fimiani
Journal:  Clin Exp Dermatol       Date:  2003-07       Impact factor: 3.470

2.  Further evidence for an autosomal dominant form of oculoauriculovertebral dysplasia.

Authors:  L Regenbogen; V Godel; V Goya; R M Goodman
Journal:  Clin Genet       Date:  1982-03       Impact factor: 4.438

3.  Goldenhar syndrome among infants born in military hospitals to Gulf War veterans.

Authors:  M R Araneta; C A Moore; R S Olney; L D Edmonds; J A Karcher; C McDonough; K M Hiliopoulos; K M Schlangen; G C Gray
Journal:  Teratology       Date:  1997-10

4.  Encephalocraniocutaneous lipomatosis and the Proteus syndrome: distinct entities with overlapping manifestations.

Authors:  S McCall; M I Ramzy; J K Curé; G S Pai
Journal:  Am J Med Genet       Date:  1992-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.